J. Goldman & CO LP Pacira Bio Sciences, Inc. Transaction History

J. Goldman & CO LP

$3.75 Billion
Q2 2025

A detailed history of J. Goldman & CO LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 656,564 shares of PCRX stock, worth $16.3 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

656,564

Previous 859,131 23.58%

Holding current value

$16.3 Million

Previous $21.3 Million 26.5%

% of portfolio

0.42%

Previous 0.56%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$22.91 - $27.14 $4.64 Million - $5.5 Million	-202,567 Reduced 23.58%	656,564 $15.7 Million
Q1 2025 May 15, 2025	BUY	$18.33 - $27.25 $13.4 Million - $19.9 Million	731,988 Added 575.72%	859,131 $21.3 Million
Q4 2024 Feb 14, 2025	BUY	$15.3 - $20.33 $1.95 Million - $2.58 Million	127,143 New	127,143 $2.4 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $1.88 Million - $2.47 Million	51,931 New	51,931 $2.08 Million
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $1.15 Million - $2.04 Million	-40,325 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $1.82 Million - $2.35 Million	-50,093 Reduced 55.4%	40,325 $1.83 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $3.31 Million - $4.34 Million	90,418 New	90,418 $3.93 Million
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $1.18 Million - $1.87 Million	-35,895 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $987,112 - $1.43 Million	35,895 New	35,895 $1.15 Million
Q4 2017 Feb 14, 2018	SELL	$31.85 - $46.95 $6.48 Million - $9.55 Million	-203,400 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $7.26 Million - $8.03 Million	203,400	203,400 $7.64 Million

Others Institutions Holding PCRX

# of Institutions

256

Shares Held

51.5M

Call Options Held

289K

Put Options Held

130K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.14B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Account